Ludwig-Maximilians-Universität (LMU)

University / College


Location: München, Germany (DE) DE

ISNI: 000000041936973X

ROR: https://ror.org/05591te55

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Itching in Atopic Dermatitis: Patient-and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany (2023) Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, Abraham S, et al. Journal article Multiclass prediction of different dementia syndromes based on multi-centric volumetric MRI imaging (2023) Lampe L, Huppertz HJ, Anderl-Straub S, Albrecht F, Ballarini T, Bisenius S, Mueller K, et al. Journal article Data-Driven Allocation of Preventive Care with Application to Diabetes Mellitus Type II (2023) Kraus M, Feuerriegel S, Saar-Tsechansky M Journal article Guidelines for mouse and human DC functional assays (2022) Clausen BE, Amon L, Backer RA, Berod L, Bopp T, Brand A, Burgdorf S, et al. Journal article Spatial proteomics in three-dimensional intact specimens (2022) Bhatia HS, Brunner AD, Oeztuerk F, Kapoor S, Rong Z, Mai H, Thielert M, et al. Journal article Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry (2022) Hanschmann T, Francuzik W, Doelle-Bierke S, Hofmeier KS, Grabenhenrich L, Rueff F, Renaudin JM, et al. Journal article eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms (2022) Kaufmann M, Steeb T, Wessely A, Meyerolbersleben M, French LEE, Berking C, Heppt M Journal article A FHIR has been lit on gICS: facilitating the standardised exchange of informed consent in a large network of university medicine (2022) Bialke M, Geidel L, Hampf C, Blumentritt A, Penndorf P, Schuldt R, Moser FM, et al. Journal article Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections (2022) Ahmed MIM, Diepers P, Janke C, Plank M, Eser TM, Rubio-Acero R, Fuchs A, et al. Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article